Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Bristol-Myers Squibb.
4th Annual International Congress on Immunotherapies in Cancer®: Focus on Practice-Changing Application
Saturday, December 14, 2019
InterContinental New York Times Square
300 West 44th Street
New York, NY 10036
The recent development of immunotherapies to treat cancer has transformed the way that clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.
“But how do I use this information to manage my patients with cancer?”
This is the key question, and the one whose answer ultimately means the most for your patients. The 4th Annual International Congress on Immunotherapies in Cancer®: Focus on Practice-Changing Application will answer that question. This exciting and fast-paced congress will provide a multi-module, curriculum-based program that focuses exclusively on immunotherapies and their application to the management of cancer. This intensive, 1-day interactive program will provide a comprehensive review of the key data sets that are most relevant to the application of these novel strategies for the clinician who manages some of the most difficult-to-treat forms of cancer. The program will focus on the practical application of recent clinical trial results that have shaped current and evolving clinical management, evolving biomarker information, the latest basic science findings, and the most highly anticipated clinical trials in the field.
Topics of particular interest will be optimal timing of checkpoint inhibitors, identification of patients with cell surface expression of a target antigen who would be good candidates for CAR T-cell treatment, using combination immunotherapies in patients with driver mutations (eg, EGFR/ALK), and the use of combination therapies targeting the IDO pathway in patients with advanced melanoma.
This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of patients with cancer.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Bristol-Myers Squibb and Pfizer.
Professor of Medicine
Director, Thoracic Oncology
Co-Director, Cancer Immunotherapy Program
Price Chair, Clinical Translational Research
New York-Presbyterian/Columbia University Irving Medical Center
New York, NY
Professor, Internal Medicine (Medical Oncology)
Leader, Melanoma Disease Related Translational Team
Co-Leader, Cancer Immunology Program
Yale School of Medicine
Yale Cancer Center
New Haven, CT
RegistrationRegistration fees include buffet breakfast, breaks, and e-syllabus materials.
2 Ways to Register
- Online: Click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
|Nurses, PAs, Other Health Care Professionals||$99||$149|
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email firstname.lastname@example.org, or call (888) 949-0045 or (609) 378-3701.
A cancellation fee of 25% will be assessed on refunds requested through and including November 2, 2019, and a 50% fee on refunds requested on November 3, 2019 through November 30, 2019. No refunds will be made after November 30, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.
You must be logged in to PER to register for this meeting
Or Register for PER now